化学結合型Fab
Journal of Immunology 139 (7): 2367–2375. PMID 2958547.
1 2 Borchmann, P.; Schnell, R.; Fuss, I.; Manzke, O.; Davis, T.; Lewis, L. D.; Behnke, D.; Wickenhauser, C. et al. (2002). “Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma”. Blood 100 (9): 3101–3107. doi:10.1182/blood-2001-12-0295. PMID 12384405.
↑ Link, B. K.; Kostelny, S. A.; Cole, M. S.; Fusselman, W. P.; Tso, J. Y.; Weiner, G. J. (1998). “Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms”.